ADK-918АДК-918
The para-bromobenzamide counterpart of Chlodantane, N-(adamantan-2-yl)-4-bromobenzamide. It is chemically distinct from Bromantane.
What the studies found
Animal research · 2023
Comparative Evaluation of the Pharmacological Activity of Fatty Aromatic Amides and Amines with a Framework Moiety and Their Non-Covalent Complexes
Findings for this preparation
Complexation of ADK-918 neutralized its actoprotective effect in the tested animal preparation. The treadmill improvement reported for a separate camphane candidate is not an ADK-918 benefit.
Study notes · methods, sources and limitations
Participants or model Mouse pharmacology experiments
Important limitations
- Abstract-level animal findings do not establish human performance benefits or improved clinical safety. An effect at a 14-day assessment does not prove a benefit persisted for 14 days after one dose. The Russian and English versions are one publication, not independent replication.
Pharmaceutical Chemistry Journal. 57(4):523–534 · Publication record
Laboratory analysis · 2019
Synthesis of New Camphane-Type Amides: Potential Synthetic Adaptogenes
Study of multiple preparations
The study reports synthesis and characterization of camphane analogues and links their design to Chlodantane and related adamantanes. ADK-957 appears as a chlorophenoxyacetamide background lead; cited cold-protection activity is not a new clinical result in this chemistry paper.
Study notes · methods, sources and limitations
Participants or model Chemical synthesis and characterization; background pharmacology citations
Important limitations
- Chemical characterization and a potential-adaptogen label do not demonstrate pharmacological efficacy. ADK-957’s original cold-exposure experiment and detailed safety data remain acquisition targets.
Russian Journal of General Chemistry. 89(3):399–404 · Publication record
Animal research
Role of neurotropic adamantane-containing compounds in the regulation of immunity
Study of multiple preparations
The program reports preparation-dependent antibody-forming-cell, T-cell and post-irradiation colony responses. ADK-910 showed a strong humoral response without increasing the delayed-hypersensitivity endpoint; immune stimulation was not uniform across assays.
Study notes · methods, sources and limitations
Participants or model Multiple mouse strains and laboratory immune assays
Important limitations
- OCR transcription requires comparison with the original; author/date and full tables are not entered as verified metadata. Immune and colony assays do not demonstrate better health, infection prevention or long-term stem-cell expansion in people.
Dissertation author’s abstract; third-party Russian transcription · Dissertation; OCR reproduction
About ADK-918
Names in this research collection
ADC-918
- Compound class
- Experimental adamantane / analogue
- Research collection
- Actoprotection & occupational pharmacology · editorial grouping
- Institutions in linked studies
- See individual study records
- Source review
- Review dates and the material assessed are listed with each publication below.
Understanding the evidence
Human research
Human efficacy results unavailable
Study methods
Source-specific animal, chemistry, patent or dissertation evidence
Independent replication
Independent replication not established; translations are not separate experiments
Source access
Access and review depth appear with each linked record
Safety evidence
Human safety and interactions not established; animal activity is not a safe-use recommendation
Open a topic for the evidence assessment.
Patents and claimed inventions
These 1 grouped records distinguish claimed molecules, uses, formulations and related chemistry. Patent disclosure does not establish clinical benefit or approval.
Status is an indexed snapshot, not an official legal assessment. Search the patent collection and read the method →
Findings by study
Animal research · 2023
Comparative Evaluation of the Pharmacological Activity of Fatty Aromatic Amides and Amines with a Framework Moiety and Their Non-Covalent Complexes
Complexation of ADK-918 neutralized its actoprotective effect in the tested animal preparation. The treadmill improvement reported for a separate camphane candidate is not an ADK-918 benefit.
Study notes and original source
Comparative Evaluation of the Pharmacological Activity of Fatty Aromatic Amides and Amines with a Framework Moiety and Their Non-Covalent Complexes
A. A. Vernigora, R. V. Brunilin, O. V. Vostrikova, et al. · Pharmaceutical Chemistry Journal. 57(4):523–534
The camphane chlorobenzamide candidate increased treadmill performance by 23.22–25.20% after 14 days of administration. Baseline group differences complicate interpretation; the text describes convergence toward control running times. Complexation of Chlodantane, Bromantane and ADK-918 neutralized their actoprotective effects in the tested preparations; the new derivatives were classified as moderately toxic.
- Population / setting
- Mouse pharmacology experiments
- Source reviewed
- Institute abstract and selected author-uploaded full-text passages checked, including the 7/14-day schedule and baseline-imbalance discussion; complete tables not independently appraised.
Study limitations
- Abstract-level animal findings do not establish human performance benefits or improved clinical safety.
- An effect at a 14-day assessment does not prove a benefit persisted for 14 days after one dose.
- The Russian and English versions are one publication, not independent replication.
Reviewed 2026-10-03.
Laboratory analysis · 2019
Synthesis of New Camphane-Type Amides: Potential Synthetic Adaptogenes
The study reports synthesis and characterization of camphane analogues and links their design to Chlodantane and related adamantanes. ADK-957 appears as a chlorophenoxyacetamide background lead; cited cold-protection activity is not a new clinical result in this chemistry paper.
Study notes and original source
Synthesis of New Camphane-Type Amides: Potential Synthetic Adaptogenes
I. A. Novakov, R. V. Brunilin, G. M. Butov, A. A. Vernigora, M. B. Navrotskii, A. S. Yablokov, S. N. Voloboev · Russian Journal of General Chemistry. 89(3):399–404
The study reports synthesis and characterization of camphane analogues and links their design to Chlodantane and related adamantanes. ADK-957 appears as a chlorophenoxyacetamide background lead; cited cold-protection activity is not a new clinical result in this chemistry paper.
- Population / setting
- Chemical synthesis and characterization; background pharmacology citations
- Source reviewed
- Author-uploaded paper’s accessible chemistry/background passages checked; earlier pharmacology not independently recovered.
Study limitations
- Chemical characterization and a potential-adaptogen label do not demonstrate pharmacological efficacy.
- ADK-957’s original cold-exposure experiment and detailed safety data remain acquisition targets.
Reviewed 2026-10-03.
Animal research · Year unconfirmed
Role of neurotropic adamantane-containing compounds in the regulation of immunity
The program reports preparation-dependent antibody-forming-cell, T-cell and post-irradiation colony responses. ADK-910 showed a strong humoral response without increasing the delayed-hypersensitivity endpoint; immune stimulation was not uniform across assays.
Study notes and original source
Role of neurotropic adamantane-containing compounds in the regulation of immunity
· Dissertation; OCR reproduction
Format: Dissertation abstract transcription · Reviewed: See scope
· Dissertation author’s abstract; third-party Russian transcription
The program reports preparation-dependent antibody-forming-cell, T-cell and post-irradiation colony responses. ADK-910 showed a strong humoral response without increasing the delayed-hypersensitivity endpoint; immune stimulation was not uniform across assays.
- Population / setting
- Multiple mouse strains and laboratory immune assays
- Source reviewed
- Selected source passages checked; complete methods and risk of bias not appraised.
Study limitations
- OCR transcription requires comparison with the original; author/date and full tables are not entered as verified metadata.
- Immune and colony assays do not demonstrate better health, infection prevention or long-term stem-cell expansion in people.
Reviewed 2026-10-03.
Animal research · 1996
Influence of hereditary and environmental factors on cytochrome P450 metabolic activity and drug effects
ADK-559/591/676/677 weakly inhibited hepatic monooxygenases; ADK-709/790/828/829/910/918 induced P450. The author also reports fewer anaphylaxis deaths with ADK-828 and ADK-829 in guinea pigs. Different controls and OCR table ambiguities prevent a reliable cross-compound ranking.
Study notes and original source
Influence of hereditary and environmental factors on cytochrome P450 metabolic activity and drug effects
· Dissertation; OCR reproduction
Format: Dissertation abstract transcription · Reviewed: See scope
T. G. Khlopushina · Doctoral dissertation author’s abstract. Moscow, 1996
ADK-559/591/676/677 weakly inhibited hepatic monooxygenases; ADK-709/790/828/829/910/918 induced P450. The author also reports fewer anaphylaxis deaths with ADK-828 and ADK-829 in guinea pigs. Different controls and OCR table ambiguities prevent a reliable cross-compound ranking.
- Population / setting
- Mouse hepatic-enzyme screening and sensitized guinea-pig anaphylaxis experiments
- Source reviewed
- Selected source passages checked; complete methods and risk of bias not appraised.
Study limitations
- Original structures and tables require checking against the scan; transcription errors are possible.
- Enzyme induction does not establish detoxification benefits or predict safe human drug combinations.
- Animal anaphylaxis results are not evidence for treating allergy in people; proposed adjunct uses were development suggestions.
Reviewed 2026-10-03.
Experiment described in a patent · 1996
Original Chlodantane and ADK-918 certificate: environmental resistance and immunostimulation
The abstract claims protection during overheating, hypobaric hypoxia and water deprivation, and improved rat operant activity under fatigue. Filing dates to 13 July 1989; publication was 10 June 1996.
Study notes and original source
Original Chlodantane and ADK-918 certificate: environmental resistance and immunostimulation
· SU1646256A1
The abstract claims protection during overheating, hypobaric hypoxia and water deprivation, and improved rat operant activity under fatigue. Filing dates to 13 July 1989; publication was 10 June 1996.
Results and tables
Reported patent results
Experimental results unavailable in the source
Experimental results could not be extracted from the accessed source; the later Chlodantane formulation patent is a separate disclosure.
The accessed Google Patents entry supplies bibliographic identity but no readable experimental description.
Population or model The accessed Google Patents entry supplies bibliographic identity but no readable experimental description.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Original experimental outcomes | Not available in the accessed bibliographic entry | No animal survival percentage or human performance effect is invented |
The original certificate is unavailable. Whether it contains experimental results remains unknown.
Source for these results ↗ · Reviewed 2026-11-06
- Population / setting
- The accessed Google Patents entry supplies bibliographic identity but no readable experimental description.
- Source reviewed
- Bibliographic index entry accessed. No readable original experimental description or results tables were available; quantitative extraction requires the original publication.
Study limitations
- Only the patent abstract and metadata were recovered; the two experimental tables remain unavailable.
- Abstract toxicity figures lack adequate species/route context here and are not used to rank safety.
Reviewed 2026-11-06.
Experiment described in a patent · 2018
Phenoxyacetamide structural analogues of Chlodantane and ADK-918
The patent explicitly identifies its two adamantane-containing phenoxyacetamides as structural analogues of ADK-910 and ADK-918. This documents a later medicinal-chemistry branch, not demonstrated clinical superiority.
Study notes and original source
Phenoxyacetamide structural analogues of Chlodantane and ADK-918
· RU2660654C1; Volgograd State Technical University
The patent explicitly identifies its two adamantane-containing phenoxyacetamides as structural analogues of ADK-910 and ADK-918. This documents a later medicinal-chemistry branch, not demonstrated clinical superiority.
Results and tables
Reported patent results
Reported findings
The disclosure reports synthesis yields; it does not supply a verified clinical adaptogenic result.
Chemical preparation and characterization of two new phenoxyacetamide analogues, with the original ADK compounds used as structural context.
Population or model Chemical preparation and characterization of two new phenoxyacetamide analogues, with the original ADK compounds used as structural context.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Analogue 1 recovery | 15.1 g, 85% yield | Manufacturing result for the newly claimed analogue, not Chlodantane or ADK-918 |
| Analogue 2 recovery | 80% yield; melting interval 94.5–95.0°C | A different new analogue; analytical characterization |
Chemical yields do not establish biological adaptogenic activity. The claimed compounds are structural analogues of the reference candidates, not the candidates themselves.
Source for these results ↗ · Reviewed 2026-11-06
- Population / setting
- Chemical preparation and characterization of two new phenoxyacetamide analogues, with the original ADK compounds used as structural context.
- Source reviewed
- Source identity and selected abstract or text passages checked; complete methods not appraised.
Study limitations
- Chemistry and preclinical observations do not establish human efficacy or safety.
Reviewed 2026-11-06.
Related compound research
Follow shared publications or research classes. These links do not establish equivalent effects between compounds.
Research collection curated by @PepMariner · editorial standards. Send a source correction ↗
Browse bibliography & PDFs ↗